# FDA Inspection 1205111 - Solvias France - September 23, 2022

Source: https://www.keypedia.com/records/fda_inspections/solvias-france/23b68b73-907e-4d10-87ae-a4ceff42e5ad
Source feed: FDA_Inspections

> FDA Inspection 1205111 for Solvias France on September 23, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1205111
- Company Name: Solvias France
- Inspection Date: 2022-09-23
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1065479 - 2017-07-28](https://www.keypedia.com/records/fda_inspections/solvias-france/689db66f-49cc-48a3-b94d-b80afe1b3dcf)
- [FDA Inspection 875386 - 2014-03-27](https://www.keypedia.com/records/fda_inspections/solvias-france/d593105d-c8ef-4dda-91b6-b570df0a42b4)

Company: https://www.keypedia.com/companies/solvias-france/0c44a3f5-9755-43c2-a4c9-4387bafc7d9f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c